| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |